Фромпо

Фромпо (Gefitinib) is an oral prescription medication used for certain types of cancer treatment. It belongs to the class of tyrosine kinase inhibitors and is taken as directed by a healthcare professional. This medication is designed to target specific cancer cell pathways.

Gefitinib is primarily used to treat non-small cell lung cancer (NSCLC) in patients with specific genetic mutations. It may also be prescribed for other cancer types as determined by a physician. This medication works by blocking signals that promote cancer cell growth. Patients often ask, 'what is gefitinib used for' to understand its role in cancer therapy.

Common effects of gefitinib include mild nausea, diarrhea, or skin reactions such as rash or dry skin. Some patients may experience fatigue or loss of appetite. These effects are typically temporary and vary by individual. Always consult a healthcare provider if symptoms persist.

Gefitinib should be handled with care, especially by individuals with known allergies to its components. Pregnant or breastfeeding women should avoid this medication unless advised otherwise by a doctor. Regular monitoring may be required to manage potential side effects during treatment. Keep this medication out of reach of children.

Gefitinib may interact with certain medications, including strong CYP3A4 inhibitors or inducers, which can affect its effectiveness. Patients should inform their healthcare provider about all prescription and over-the-counter drugs they are taking. Avoid grapefruit products while using this medication, as they may alter its metabolism.